Zoetis Inc (ZTS)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $34.06B
Last updated: Nov 17, 2026 at 11:06 AM ET
Zoetis Inc (ZTS) Stock Forecast
Analysts expect Zoetis (ZTS) to earn $6.29 per share in the fiscal year ending Dec 31, 2026, on revenue of $9.29B. Of 16 analysts, 5 rate the stock Buy or Strong Buy, 11 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 7 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 16 ratings average 2.50, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 31% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 18.8% |
| Buy | 2 | 12.5% |
| Hold | 11 | 68.8% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 16
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 1.4% and revenue estimates rise 0.5%.
- Fiscal year ending Dec 31, 2026
- $6.29
- EPS consensus, revenue $9.29B
- Fiscal year ending Dec 31, 2027
- $6.38
- EPS consensus, revenue $9.34B
- Next report
- Feb 10, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $6.29 | $6.19 to $6.37 | 14 | $9.29B | $9.23B to $9.32B | 13 |
| Dec 31, 2027 | $6.38 | $5.96 to $7.48 | 15 | $9.34B | $9.01B to $10.17B | 14 |
Quarterly Estimates
The EPS consensus rises from $1.20 for the quarter ending Dec 31, 2026 to $1.50 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.20 | $1.12 to $1.35 | 15 | $2.20B | $2.10B to $2.35B | 13 |
| Mar 31, 2027 | $1.50 | $1.41 to $1.57 | 9 | $2.24B | $2.18B to $2.29B | 7 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 8 upward and 8 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 7 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 6 |
| Quarter ending Mar 31, 2027 | 0 | 2 |
EPS Trend
The EPS consensus for the fiscal year ending Dec 31, 2026 is where it was 90 days ago.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $6.29 | $6.26 | $6.21 | $6.21 | $6.29 | +0.1% |
| Fiscal year ending Dec 31, 2027 | $6.38 | $6.41 | $6.54 | $6.53 | $6.73 | -5.3% |
| Quarter ending Mar 31, 2027 | $1.50 | $1.50 | $1.52 | $1.52 | $1.57 | -4.8% |
Frequently Asked Questions About ZTS
What is the ZTS stock forecast?
Consensus analyst estimates put Zoetis's EPS at $6.29 for the fiscal year ending Dec 31, 2026, on revenue of $9.29B. The consensus rating from 16 analysts is Hold.
How do analysts rate ZTS stock?
Of 16 analysts covering Zoetis, 3 rate it Strong Buy, 2 Buy, 11 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from ZTS next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $6.29, with estimates from $6.19 to $6.37 from 14 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $6.38, with estimates from $5.96 to $7.48 from 15 analysts.
What revenue do analysts expect from Zoetis next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $9.29B, with estimates from $9.23B to $9.32B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $9.34B, with estimates from $9.01B to $10.17B.
How many analysts cover ZTS?
16 analysts rate Zoetis stock, and 14 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
ZTS pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts